UB Paderborn / Katalog / Suche / in CDI

P2Y12 receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cells

Scientific reports, 2021-08, Vol.11 (1), p.17459-17459, Article 17459

2021

Link zum Volltext

Verfügbarkeit prüfen

D-dimer and fibrinogen indicate ischemic risk in patients with atrial fibrillation after percutaneous coronary intervention

Thrombosis journal, 2024-05, Vol.22 (1), p.42-42, Article 42

2024

Link zum Volltext

Verfügbarkeit prüfen

Platelet Bone Morphogenetic Protein-4 Mediates Vascular Inflammation and Neointima Formation after Arterial Injury

Cells (Basel, Switzerland), 2021-08, Vol.10 (8), p.2027

2021

Link zum Volltext

Verfügbarkeit prüfen

Medical history of coronary artery disease and time to electrocardiogram in the emergency department: a real-life, single-center, retrospective analysis

BMC cardiovascular disorders, 2021-10, Vol.21 (1), p.480-480, Article 480

2021

Link zum Volltext

Verfügbarkeit prüfen

The Ratio of ADP- to TRAP-Induced Platelet Aggregation Quantifies P2Y12-Dependent Platelet Inhibition Independently of the Platelet Count

PloS one, 2016-02, Vol.11 (2), p.e0149053-e0149053

2016

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulation and anaemia: old opponents from the era of VKA?

European heart journal, 2019-12, Vol.40 (46), p.3791-3792

2019

Link zum Volltext

Verfügbarkeit prüfen

Dual-Pathway Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention in Stable Coronary Artery Disease: A Single-Center, Single-Operator, Retrospective Cohort Study

Frontiers in medicine, 2020-09, Vol.7, p.414-414

2020

Link zum Volltext

Verfügbarkeit prüfen

Is Bleeding Always Bad?: Bad Boy Bleeding

Journal of the American College of Cardiology, 2019-09, Vol.74 (12), p.1529-1531

2019

Link zum Volltext

Verfügbarkeit prüfen

Thrombelastography Compared with Multiple Impedance Aggregometry to Assess High On-Clopidogrel Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Journal of clinical medicine, 2022-07, Vol.11 (14), p.4237

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Serum Serotonin as a Biomarker for Myocardial Infarction and Ischemia/Reperfusion Injury

Applied sciences, 2020-09, Vol.10 (18), p.6379

2020

Link zum Volltext

Verfügbarkeit prüfen

Use and Outcomes of Acute Treatment Strategies in Patients with Severe Aortic Valve Stenosis

Global heart, 2021-01, Vol.16 (1), p.91-91

2021

Link zum Volltext

Verfügbarkeit prüfen

Why digital health trials can fail: Lessons learned from a randomized trial of health coaching and virtual cardiac rehabilitation

Cardiovascular digital health journal, 2021-04, Vol.2 (2), p.101-108

2021

Link zum Volltext

Verfügbarkeit prüfen

Triple antithrombotic therapy in cardiac patients: more questions than answers

European heart journal, 2014-01, Vol.35 (4), p.216-223

2014

Link zum Volltext

Verfügbarkeit prüfen

Time from blood draw to multiple electrode aggregometry and association with platelet reactivity

Journal of thrombosis and thrombolysis, 2023-01, Vol.55 (1), p.134-140

2023

Link zum Volltext

Verfügbarkeit prüfen

TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran

Thrombosis research, 2016-02, Vol.138, p.63-68

2016

Link zum Volltext

Verfügbarkeit prüfen

Early platelet dysfunction in patients receiving extracorporeal membrane oxygenation is associated with mortality

Journal of thrombosis and thrombolysis, 2022-04, Vol.53 (3), p.712-721

2022

Link zum Volltext

Verfügbarkeit prüfen

Low on-clopidogrel ADP- and TRAP-6-induced platelet aggregation in patients with atrial fibrillation undergoing percutaneous coronary intervention: an observational pilot study

Journal of thrombosis and thrombolysis, 2024-03, Vol.57 (3), p.361-369

2024

Link zum Volltext

Verfügbarkeit prüfen

Dabigatran and rivaroxaban do not affect AA- and ADP-induced platelet aggregation in patients receiving concomitant platelet inhibitors

Journal of thrombosis and thrombolysis, 2016-08, Vol.42 (2), p.161-166

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation

European heart journal open, 2023-07, Vol.3 (4), p.oead065-oead065

2023

Link zum Volltext

Verfügbarkeit prüfen

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial

The Lancet. Haematology, 2022-08, Vol.9 (8), p.e585-e593

2022

Link zum Volltext

Verfügbarkeit prüfen

Cangrelor in patients with percutaneous coronary intervention for acute myocardial infarction after cardiac arrest and/or with cardiogenic shock

European heart journal. Acute cardiovascular care, 2023-07, Vol.12 (7), p.462-463

2023

Link zum Volltext

Verfügbarkeit prüfen

Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry

Thrombosis and haemostasis, 2014-02, Vol.111 (2), p.266

2014

Link zum Volltext

Verfügbarkeit prüfen

Moderate ischemic mitral regurgitation: coronary artery bypass grafting with versus without simultaneous treatment of the mitral valve

Journal of cardiovascular surgery, 2018-12, Vol.59 (6), p.830

2018

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulant and antiplatelet therapy choices for patients with atrial fibrillation one year after coronary stenting or acute coronary syndrome

Expert opinion on drug safety, 2018-03, Vol.17 (3), p.251-258

2018

Link zum Volltext

Verfügbarkeit prüfen

Accuracy of Event Rate and Effect Size Estimation in Major Cardiovascular Trials: A Systematic Review

JAMA network open, 2024-04, Vol.7 (4), p.e248818

2024

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

P2Y12 receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cells

D-dimer and fibrinogen indicate ischemic risk in patients with atrial fibrillation after percutaneous coronary intervention

Platelet Bone Morphogenetic Protein-4 Mediates Vascular Inflammation and Neointima Formation after Arterial Injury

Medical history of coronary artery disease and time to electrocardiogram in the emergency department: a real-life, single-center, retrospective analysis

The Ratio of ADP- to TRAP-Induced Platelet Aggregation Quantifies P2Y12-Dependent Platelet Inhibition Independently of the Platelet Count

Anticoagulation and anaemia: old opponents from the era of VKA?

Dual-Pathway Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention in Stable Coronary Artery Disease: A Single-Center, Single-Operator, Retrospective Cohort Study

Is Bleeding Always Bad?: Bad Boy Bleeding

Thrombelastography Compared with Multiple Impedance Aggregometry to Assess High On-Clopidogrel Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Evaluation of Serum Serotonin as a Biomarker for Myocardial Infarction and Ischemia/Reperfusion Injury

Use and Outcomes of Acute Treatment Strategies in Patients with Severe Aortic Valve Stenosis

Why digital health trials can fail: Lessons learned from a randomized trial of health coaching and virtual cardiac rehabilitation

Triple antithrombotic therapy in cardiac patients: more questions than answers

Time from blood draw to multiple electrode aggregometry and association with platelet reactivity

TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran

Early platelet dysfunction in patients receiving extracorporeal membrane oxygenation is associated with mortality

Low on-clopidogrel ADP- and TRAP-6-induced platelet aggregation in patients with atrial fibrillation undergoing percutaneous coronary intervention: an observational pilot study

Dabigatran and rivaroxaban do not affect AA- and ADP-induced platelet aggregation in patients receiving concomitant platelet inhibitors

Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Cangrelor in patients with percutaneous coronary intervention for acute myocardial infarction after cardiac arrest and/or with cardiogenic shock

Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry

Moderate ischemic mitral regurgitation: coronary artery bypass grafting with versus without simultaneous treatment of the mitral valve

Anticoagulant and antiplatelet therapy choices for patients with atrial fibrillation one year after coronary stenting or acute coronary syndrome

Accuracy of Event Rate and Effect Size Estimation in Major Cardiovascular Trials: A Systematic Review

Suchergebnisse filtern